Angkana Charoenyingwattana

Title: Angkana Charoenyingwattana: Pioneering Collaborations in Risk Assessment for Cutaneous Adverse Drug Reactions

Introduction:

Angkana Charoenyingwattana, based in Bangkok, TH, is a talented innovator who has made significant contributions to the field of risk assessment for cutaneous adverse drug reactions. Through her impressive work, she has developed a pioneering method that predicts the risk of patients developing cutaneous adverse drug reactions to certain antiretroviral agents. With her collaboration with esteemed organizations and notable individuals, Angkana's contributions have paved the way for improved drug safety.

Latest Patents:

One of Angkana Charoenyingwattana's noteworthy patents is centered around risk assessment for cutaneous adverse drug reactions from antiretroviral agents. The invention utilizes the HLA-B*3505 allele and polymorphisms in the CCHCR1 gene to predict the likelihood of patients developing cutaneous adverse reactions to non-nucleoside reverse transcriptase inhibitors, like nevirapine. This patent underscores her dedication to advancing patient safety in the context of drug therapy.

Career Highlights:

Angkana's academic journey has seen her flourish at esteemed institutions such as Mahidol University and Riken Corporation. Her commitment to pharmaceutical research and innovation has been evident throughout her career, and she has earned recognition for her work, including publications and contributions to scientific conferences.

Collaborations:

Throughout her career, Angkana Charoenyingwattana has actively collaborated with esteemed individuals and organizations to further her research and bring innovative ideas to the forefront. Notably, she has worked alongside renowned researchers such as Somnuek Sungkanuparph and Sasisopin Kiertiburanakul to assess the risks associated with cutaneous adverse drug reactions.

Conclusion:

Angkana Charoenyingwattana's expertise in risk assessment for cutaneous adverse drug reactions and her collaboration with prominent individuals and organizations have contributed significantly to the field of pharmaceutical innovation. Her groundbreaking patent showcases her innovative approach to predicting and preventing adverse reactions in patients. As an accomplished inventor and researcher, Angkana continues to push the boundaries of drug safety, improving patient outcomes and healthcare practices.